Literature DB >> 30827271

Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus.

Tareq Hossan1, Shoumik Kundu1, Sayeda Sadia Alam1, Sankari Nagarajan2.   

Abstract

BACKGROUND AND
OBJECTIVE: Type 2 diabetes mellitus (T2DM) is a multifactorial metabolic disorder. Pancreatic β-cell dysfunction and insulin resistance are the most common and crucial events of T2DM. Increasing evidence suggests the association of epigenetic modifications with the pathogenesis of T2DM through the changes in important biological processes including pancreatic β- cell differentiation, development and maintenance of normal β-cell function. Insulin sensitivity by the peripheral glucose uptake tissues is also changed by the altered epigenetic mechanisms. In this review, we discussed the major epigenetic alterations and their effects on β-cell function, insulin secretion and insulin resistance in context of T2DM.
METHODS: We investigated the presently available epigenetic modifications including DNA methylation, posttranslational histone modifications, ATP-dependent chromatin remodeling and non-coding RNAs related to the pathogenesis of T2DM. Published literatures on this topic were searched both on Google Scholar and Pubmed with related keywords and investigated for relevant information.
RESULTS: The epigenetic modifications introduce changes in gene expression which are essential for appropriate β-cell development and functions, insulin secretion and sensitivity resulting in the pathogenesis of T2DM. Interestingly, T2DM could also be a prominent reason for the mentioned epigenetic alterations.
CONCLUSION: This review article emphasized on the epigenetic modifications associated with T2DM and discussed the consequences in deterioration of the disease condition. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  ATP-dependent chromatinzzm321990remodeling; DNA methylation; Type 2 diabetes mellitus; epigenetic; histone modification; insulin resistance; non-coding RNA; β cell.

Mesh:

Year:  2019        PMID: 30827271     DOI: 10.2174/1871530319666190301145545

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  3 in total

1.  Exendin-4 may improve type 2 diabetes by modulating the epigenetic modifications of pancreatic histone H3 in STZ-induced diabetic C57BL/6 J mice.

Authors:  Peipei Tu; Bin Huang; Minggang Li; Yaofang Zhang; Shixiang Bao; Na Tu; Yanan Yang; Jingtao Lu
Journal:  J Physiol Biochem       Date:  2021-08-19       Impact factor: 4.158

2.  Association Between a Novel Metabolic Score for Insulin Resistance and Mortality in People With Diabetes.

Authors:  Zhenwei Wang; Jing Xie; Junjie Wang; Wei Feng; Naifeng Liu; Yun Liu
Journal:  Front Cardiovasc Med       Date:  2022-05-12

3.  Clinical and molecular features of two diabetes families carrying mitochondrial ND1 T3394C mutation.

Authors:  Xiaohong You; Xueming Huang; Luowen Bi; Rui Li; Lin Zheng; Changzheng Xin
Journal:  Ir J Med Sci       Date:  2021-04-11       Impact factor: 1.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.